Page 3 - Pharmacy Compounding News Today

The FDA has released 

The start of cold and flu season has led to a spike in respiratory illness and also a shortage of amoxicillin oral suspension. Hospitals and some pharmacies would like to be able to compound amoxicillin suspension from commercially available amoxicillin tablets or capsules.

This annual award recognizes excellence and leadership in pharmacy compounding....

In a Sept.16 letter to National Association of Boards of Pharmacy CEO Al Carter, FDA states that desiccated thyroid extract products can put patients at harm and that therapies containing DTE require a biologics license application. The letter encouraged NABP to share the letter with its members, the state boards of pharmacy. Carter relayed the information to boards of pharmacy on Sept. 22.

After last month’s Energy and Commerce Committee dust-up over the future of CURES 2.0 Lauren had a question for the legislation’s Republican champion.

KANSAS CITY, Mo. (Oct. 2, 2022) – Jim Martin, a pharmacist licensed in both Georgia and Texas, received the National Community Pharmacists Association’s 2022 Calvin J. Anthony Lifetime Achievement Award as part of NCPA’s Annual Convention, which was held Oct. 1-4, in Kansas City, Mo.

In a letter to the Alliance for Pharmacy Compounding, the Center for Veterinary Medicine at FDA has agreed to delay the enforcement of animal compounding GFI 256, “Compounding Animal Drugs from Bulk Drug Substances – Guidance for Industry” to April 2023. Enforcement had originally been slated to start on Oct. 1, 2022.

The Alliance for Pharmacy Compounding has designated Sept. 15 as Compounding Advocacy Day. APC would like to supplement its APC’s Compounders on Capitol Hill event and congressional visits that day with supportive messaging from compounders back home. Even if you’re unable to attend that day, you and your team members can still advocate from afar. Details are coming soon. Check out this page starting Wednesday for ideas to promote the day.

Do you compound hormones, or know physicians who prescribe compounded hormones? The Alliance for Pharmacy Compounding is asking NCPA members to send prescribing physicians a sign-on letter for them to send to FDA Commissioner Robert Califf (with copies going to congressional leaders) urging the commissioners not to restrict compounded hormone therapy based on a discredited report it commissioned, and instead to base any decision about compounded hormones on solid evidence.

Do you compound hormones, or know physicians who prescribe compounded hormones? The Alliance for Pharmacy Compounding is asking NCPA members to send prescribing physicians a sign-on letter for them to send to FDA Commissioner Robert Califf (with copies going to congressional leaders) urging the commissioners not to restrict compounded hormone therapy based on a discredited report it commissioned, and instead to base any decision about compounded hormones on solid evidence.